Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of amitriptyline in cystic fibrosis patients with Pseudomonas aeruginosa infection
2006-002259-33Phase 2Completed
- Sponsor
- Paediatrisches Sekretariat für Klinische Studien
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of amitriptyline in cystic fibrosis (CF) and Pseudomonas aeruginosa airway infection, sponsored by Paediatrisches Sekretariat für Klinische Studien. Primary endpoint: Lung function: FEV1. Started Jul 2006; status: completed.
02
Drugs
amitriptyline
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa airway infection
Beyond the preview
Go deeper on 2006-002259-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002259-33.